AMRN - Amarin Corporat Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 VXX (%) AAPL (%) SPY (%) UGAZ (%) ORMP (%) NK (%) MRNS (%) MDB (%) M (%) LTCUSD (%) JNCE (%) JAKK (%) HST (%) HIIQ (%) FTSV (%) FSLY (%) FB (%) EXPR (%) ETHUSD (%) EOSUSD (%) DLTR (%) DGAZ (%) CVX (%) CGIX (%) CGC (%)

AMRN - Amarin Corporation p...

$22.99 0.18[%]

15 mins delayed data

People also watch : AZN | IONS | ABBV | ALKS | TEVA | GSK

+Watchlist

6 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$22.81	Open	$22.84
Volume	5.94M	Market Cap	6.041B
Yield		Last Dividend

Day

52 Week

Is Amarin Corporation (AMRN) Stock Outpa...	12/11/19
Is (AMRN) Outperforming Other Medical Stocks This Year?

All Eyes on These 3 Biotech Stocks Ahead...	12/09/19
Searching for the stocks that can treat you to huge rewards overnight? Look no further than the biotech industry. Regardless of trade wars, economic d...

Acquisition Rumors Aren’t the Only Thing...	12/06/19
It's been three weeks since the U.S. Food and Drug Administration recommended that Amarin's (NASDAQ:AMRN) prescription-strength fish oil drug,...

These Hedge Funds Cashed Out Of Amarin C...	12/03/19
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world pr...

Amarin (AMRN) is a Great Momentum Stock:...	12/03/19
Does Amarin (AMRN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Amarin's Vascepa MAA for Heart Risk ...	12/03/19
The EMA validates Amarin's (AMRN) regulatory application seeking approval for Vascepa as a treatment to reduce risk of cardiovascular events.

Do Options Traders Know Something About ...	12/02/19
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

Heart Drugs Are Having a Moment	12/02/19
(Bloomberg Opinion) -- Drugmakers have spent years de-emphasizing heart medications in favor of higher-priced treatments for cancer and rare diseases....

European Medicines Agency Accepts for Re...	12/02/19
Amarin Corporation plc (AMRN), a pharmaceutical company focused on improving cardiovascular health, announced today that the European Medicines Agency...

Amarin Corporation plc's (NASDAQ:AMR...	12/02/19
Amarin Corporation plc's (NASDAQ:AMRN): Amarin Corporation plc, a pharmaceutical company, engages in the development...

Why A Stock Market Correction Would Be A...	11/27/19
Financial advisor Patrick Healey shares why a small stock market correction is needed in the current investing environment — and how to deal with inve...

ANALYST RATINGS

4 analyst ratings (Last 6 months)

25.00 %

Strong Buy + Buy

Price Target (PT)

Underperform rating	11/20/19
Oppenheimer initiates coverage with Underperform rating and announces Price Target of $7.00

Hold rating	11/18/19
Citi downgrades from Buy to Neutral rating and raises Price Target from $23.00 to $27.00

Buy rating	10/31/19
Aegis Capital initiates coverage with Buy rating and announces Price Target of $23.00

Hold rating	10/15/19
Goldman Sachs initiates coverage with Neutral rating and announces Price Target of $17.00

EARNINGS

Date	2019-11-05 (BMO)	Est. (EPS/Rev.)	($0.05)/ 111.04M
Actual (EPS/Rev.)	$-0.01/ $112.41 M	EPS (TTM)	0

TRADERS TRACKING $AMRN

Service Name	Trader	% Success
Big Data Kornacki & Zhou	Zhou Academy	86.00 %	Subscribe
Alpha Swing Trades	Jonathan	69.00 %	Follow
Option short-term trading [Unusual]	Debashis K	64.00 %	Subscribe
Swingers Corner	Akemi Mokoto	43.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.